Subbu Nambi
Stock Analyst at Guggenheim
(3.59)
# 2,917
Out of 4,829 analysts
38
Total ratings
45.45%
Success rate
10.57%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ILMN Illumina | Maintains: Buy | $122 → $114 | $81.57 | +39.76% | 3 | May 9, 2025 | |
| TWST Twist Bioscience | Reiterates: Buy | $50 | $32.95 | +51.75% | 2 | May 6, 2025 | |
| DHR Danaher | Reiterates: Buy | $250 | $200.83 | +24.48% | 1 | Apr 23, 2025 | |
| CYRX Cryoport | Reiterates: Buy | $10 | $7.15 | +39.86% | 1 | Apr 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $60 | $53.40 | +12.36% | 2 | Apr 11, 2025 | |
| NEOG Neogen | Maintains: Buy | $15 → $13 | $6.50 | +100.00% | 2 | Apr 10, 2025 | |
| MYGN Myriad Genetics | Downgrades: Neutral | n/a | $4.25 | - | 2 | Apr 9, 2025 | |
| VCYT Veracyte | Maintains: Buy | $45 → $37 | $30.76 | +20.29% | 3 | Apr 9, 2025 | |
| TEM Tempus AI | Reiterates: Buy | n/a | $62.69 | - | 2 | Feb 25, 2025 | |
| BRKR Bruker | Reiterates: Buy | n/a | $40.26 | - | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $56 | $41.66 | +34.42% | 5 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $200 | $157.29 | +27.15% | 2 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $35.99 | - | 1 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $3.19 | +88.38% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.72 | +729.88% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $9.49 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $133.72 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $17.04 | +46.71% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.10 | - | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.16 | - | 1 | Dec 14, 2023 |
Illumina
May 9, 2025
Maintains: Buy
Price Target: $122 → $114
Current: $81.57
Upside: +39.76%
Twist Bioscience
May 6, 2025
Reiterates: Buy
Price Target: $50
Current: $32.95
Upside: +51.75%
Danaher
Apr 23, 2025
Reiterates: Buy
Price Target: $250
Current: $200.83
Upside: +24.48%
Cryoport
Apr 16, 2025
Reiterates: Buy
Price Target: $10
Current: $7.15
Upside: +39.86%
Exact Sciences
Apr 11, 2025
Reiterates: Buy
Price Target: $60
Current: $53.40
Upside: +12.36%
Neogen
Apr 10, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $6.50
Upside: +100.00%
Myriad Genetics
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.25
Upside: -
Veracyte
Apr 9, 2025
Maintains: Buy
Price Target: $45 → $37
Current: $30.76
Upside: +20.29%
Tempus AI
Feb 25, 2025
Reiterates: Buy
Price Target: n/a
Current: $62.69
Upside: -
Bruker
Feb 24, 2025
Reiterates: Buy
Price Target: n/a
Current: $40.26
Upside: -
Feb 24, 2025
Reiterates: Buy
Price Target: $56
Current: $41.66
Upside: +34.42%
Jan 17, 2025
Maintains: Buy
Price Target: $170 → $200
Current: $157.29
Upside: +27.15%
Oct 17, 2024
Initiates: Neutral
Price Target: n/a
Current: $35.99
Upside: -
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $3.19
Upside: +88.38%
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $0.72
Upside: +729.88%
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $9.49
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $133.72
Upside: -
Dec 14, 2023
Initiates: Buy
Price Target: $25
Current: $17.04
Upside: +46.71%
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.10
Upside: -
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.16
Upside: -